Development of TASP0410457 (TASP457), a novel dihydroquinolinone derivative as a PET radioligand for central histamine H3 receptors.
about
[(11)C]TASP457, a novel PET ligand for histamine H3 receptors in human brain.Progress in the development of histamine H3 receptor antagonists/inverse agonists: a patent review (2013-2017).Histamine H3 receptor density is negatively correlated with neural activity related to working memory in humans.
P2860
Development of TASP0410457 (TASP457), a novel dihydroquinolinone derivative as a PET radioligand for central histamine H3 receptors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Development of TASP0410457 (TA ...... entral histamine H3 receptors.
@ast
Development of TASP0410457 (TA ...... entral histamine H3 receptors.
@en
type
label
Development of TASP0410457 (TA ...... entral histamine H3 receptors.
@ast
Development of TASP0410457 (TA ...... entral histamine H3 receptors.
@en
prefLabel
Development of TASP0410457 (TA ...... entral histamine H3 receptors.
@ast
Development of TASP0410457 (TA ...... entral histamine H3 receptors.
@en
P2093
P2860
P1433
P1476
Development of TASP0410457 (TA ...... central histamine H3 receptors
@en
P2093
Kazumi Koga
Kazunori Kawamura
Makoto Higuchi
Mari Ohmichi
Masaki Tokunaga
Masayuki Hanyu
Ming-Rong Zhang
Takafumi Minamimoto
P2860
P2888
P356
10.1186/S13550-016-0170-2
P577
2016-02-09T00:00:00Z
P5875
P6179
1050399124